Molecular targets in pulmonary fibrosis: the myofibroblast in focus.
about
Induction of pulmonary fibrosis by cerium oxide nanoparticlesAortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathwaysFibroblasts in fibrosis: novel roles and mediatorsHuman epidermal growth factor receptor signaling in acute lung injuryThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisBleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" diseaseMyofibroblasts: trust your heart and let fate decide.Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerA proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosisFibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-Pick type C2 diseaseWithaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivoCurcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndromeWhat We Talk About When We Talk About EvolutionActivated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosisMyocardial fibrosis in congenital and pediatric heart diseaseElevated circulating fibrocyte levels in patients with hypertensive heart disease.Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.Functional Wnt signaling is increased in idiopathic pulmonary fibrosisLong-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary diseasePDGF-Ralpha gene expression predicts proliferation, but PDGF-A suppresses transdifferentiation of neonatal mouse lung myofibroblasts.Cytokine inhibition in the treatment of COPD.Upregulation of gelatinases and epithelial-mesenchymal transition in small airway remodeling associated with chronic exposure to wood smoke.Grape seed proanthocyanidins prevent irradiation-induced differentiation of human lung fibroblasts by ameliorating mitochondrial dysfunction.Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosisIntegrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrityInfluence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis.Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice.Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathwayAssociation between lymph node silicosis and lung silicosis in 4,384 German uranium miners with lung cancer.Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesisObesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse modelPathogenesis of idiopathic pulmonary fibrosisActivation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β₁ is increased in chronic obstructive pulmonary disease.A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.The balance between two isoforms of LEF-1 regulates colon carcinoma growthABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.
P2860
Q23914456-3D1D713C-0E2C-4148-938C-A6508E16D41EQ24611248-43CC7FC9-0471-4300-AD1C-8B19FB9F3191Q26998508-BB9A96B4-032A-4FA9-A4DD-1C460C25C67FQ27002075-5BB0AF43-10BC-4F8A-8F95-1D67DAD99A4CQ27005980-3BC019CC-6644-473B-9E39-EDE15DF254B4Q27333940-CEB3356C-5D58-43F5-914D-D85B6A1B2D37Q27692541-526C08F3-E1FB-46AD-9600-885F9BAB6C78Q28067777-A5B36E97-AD34-4489-94FB-44B1CB4645A3Q28383207-7169F091-A8D2-4B83-AF57-6D1072F1BF7BQ28390280-42ECF359-3F4A-42A9-B5B8-C649D82BB7C4Q28477793-8C613B52-4A45-4377-B045-B4866337F058Q28482173-9BDED9BD-0906-4E7B-A937-8248D5D7D0A6Q28486257-FA4B29C0-A5CB-4817-A89C-90128BCB8070Q28603812-1F684B1A-CFB1-4525-9552-F7D67C4E1572Q28660307-20F001C6-4859-491B-B4CA-83D6CB946087Q30355582-A28B89D1-6207-4BA3-89E9-22942D80F8E1Q30419423-CDE67509-84F1-489D-AE32-DEE91FB46EC2Q30942028-A07D21AD-35ED-4676-A9CA-056F3676F064Q33334369-EB53D640-B515-46D6-AA80-7F72EEA82C96Q33551854-59D8FCD8-151A-4E68-8D3C-9718B8261CC1Q33562676-F75EB57A-CFE4-48F1-86D3-BC59663A74F5Q33568552-93AE6D5A-EE0A-4CC1-9F77-E7A1268E605CQ33573801-C58000CC-B106-4000-A22D-10C58E69395DQ33668927-11D65598-55C3-41E9-808B-75EC795C0E3FQ33698776-E93AF4FB-A70A-44CE-983D-D4E108A173ACQ33720132-DAF6EC85-0A76-4BC4-801A-CC5C4C0D3C5CQ33722844-290B1C97-EFB7-4364-911B-610E4655178AQ33738971-7B1BEFA8-7FBE-4985-96F1-C7BFD749EDE1Q33785553-F11072EC-C921-4D1C-9CA3-36748DD7D164Q33794090-98DF3BC3-A80F-448D-9733-65B2DACF24F3Q33799732-2497B701-30DC-4975-8121-F4B67061A6B3Q33825051-D4883CBA-6726-4C69-8752-32B2B3B874B1Q33825359-0DFD37A9-47E6-4443-BEE0-BAF1DEFD2679Q33906324-66299DAD-F225-4EB6-BA41-46CDA2DB28E0Q33908275-8ADAEB6D-0A0F-47A2-8530-91CC33BD99EEQ33976506-B1706AB1-5C56-4BDB-86CD-32BDF37CE14BQ34043208-6E1D3215-173E-45D2-A200-E0EC0C072984Q34116805-42361C8A-C102-4614-989A-D98DE90F8D87Q34284208-08A96093-F59C-43A1-8B75-5CA504C59B70Q34354002-D1C1A48C-C75B-490C-84B7-35535D326600
P2860
Molecular targets in pulmonary fibrosis: the myofibroblast in focus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Molecular targets in pulmonary fibrosis: the myofibroblast in focus.
@en
type
label
Molecular targets in pulmonary fibrosis: the myofibroblast in focus.
@en
prefLabel
Molecular targets in pulmonary fibrosis: the myofibroblast in focus.
@en
P356
P1433
P1476
Molecular targets in pulmonary fibrosis: the myofibroblast in focus
@en
P2093
Chris J Scotton
Rachel C Chambers
P304
P356
10.1378/CHEST.06-2568
P407
P577
2007-10-01T00:00:00Z